Gene · 2285
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic Effect of Rapamycin-Loaded Small Extracellular Vesicles Derived from Mesenchymal Stem Cells on Experimental Autoimmune Uveitis. | Front Immunol | 2022 | 35422798 | PubTator, text mining | PubMed |
| Proteolysis-targeting chimeras (PROTACs) in cancer therapy. | Mol Cancer | 2022 | 35410300 | PubTator, text mining | PubMed |
| Senotherapeutics in Cancer and HIV. | Cells | 2022 | 35406785 | PubTator, text mining | PubMed |
| Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View. | Cancers (Basel) | 2022 | 35406533 | PubTator, text mining | PubMed |
| PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway? | Front Oncol | 2022 | 35402264 | PubTator, text mining | PubMed |
| Cardiac Toxicity From Adjuvant Targeting Treatment for Breast Cancer Post-Surgery. | Front Oncol | 2022 | 35402243 | PubTator, text mining | PubMed |
| FKBP52 and FKBP51 differentially regulate the stability of estrogen receptor in breast cancer. | Proc Natl Acad Sci U S A | 2022 | 35394865 | PubTator, text mining | PubMed |
| Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches. | PLoS One | 2022 | 35390032 | PubTator, text mining | PubMed |
| Targeted protein degradation: mechanisms, strategies and application. | Signal Transduct Target Ther | 2022 | 35379777 | PubTator, text mining | PubMed |
| Autophagy and Skin Diseases. | Front Pharmacol | 2022 | 35370701 | PubTator, text mining | PubMed |
| Chemogenetics of cell surface receptors: beyond genetic and pharmacological approaches. | RSC Chem Biol | 2022 | 35359495 | PubTator, text mining | PubMed |
| The Antiarrhythmic Mechanisms of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia. | Front Physiol | 2022 | 35356081 | PubTator, text mining | PubMed |
| Author Correction: Bioinformatic and cell-based tools for pooled CRISPR knockout screening in mosquitos. | Nat Commun | 2022 | 35354810 | PubTator, text mining | PubMed |
| Sirolimus Release from Biodegradable Polymers for Coronary Stent Application: A Review. | Pharmaceutics | 2022 | 35335869 | PubTator, text mining | PubMed |
| Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias. | J Hematol Oncol | 2022 | 35331314 | PubTator, text mining | PubMed |
| The Mechanisms of Restenosis and Relevance to Next Generation Stent Design. | Biomolecules | 2022 | 35327622 | PubTator, text mining | PubMed |
| Nuclear-Mitochondrial Interactions. | Biomolecules | 2022 | 35327619 | PubTator, text mining | PubMed |
| The Role of Lipids in CRAC Channel Function. | Biomolecules | 2022 | 35327543 | PubTator, text mining | PubMed |
| Immunosuppressive Signaling Pathways as Targeted Cancer Therapies. | Biomedicines | 2022 | 35327484 | PubTator, text mining | PubMed |
| Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy. | Cancers (Basel) | 2022 | 35326708 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2285/papers?page=23